{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:15:47Z","timestamp":1791353747300,"version":"4.3.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"DOI":"10.1186\/s40814-024-01591-4","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T07:01:19Z","timestamp":1738047679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cytisine compared to combination nicotine replacement therapy to reduce cigarette consumption in relapsed smokers: protocol for a pilot randomized controlled trial"],"prefix":"10.1186","volume":"11","author":[{"given":"Hassan","family":"Mir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Heshmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri-Anne","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evyanne","family":"Quirouette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Pipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"issue":"25","key":"1591_CR1","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1016\/j.jacc.2018.10.027","volume":"72","author":"RS Barua","year":"2018","unstructured":"Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri M-A, Morris PB, et al. 2018 ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018;72(25):3332\u201365.","journal-title":"J Am Coll Cardiol"},{"issue":"17\u201318","key":"1591_CR2","doi-asserted-by":"publisher","first-page":"E484","DOI":"10.1503\/cmaj.151510","volume":"188","author":"RD Reid","year":"2016","unstructured":"Reid RD, Pritchard G, Walker K, Aitken D, Mullen K-A, Pipe AL. Managing smoking cessation. CMAJ. 2016;188(17\u201318):E484\u201392.","journal-title":"CMAJ"},{"issue":"2","key":"1591_CR3","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/bcp.12116","volume":"77","author":"HJ Aubin","year":"2014","unstructured":"Aubin HJ, Luquiens A, Berlin I. Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. Br J Clin Pharmacol. 2014;77(2):324\u201336.","journal-title":"Br J Clin Pharmacol"},{"key":"1591_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2049-6958-9-9","volume":"9","author":"E Yilmazel Ucar","year":"2014","unstructured":"Yilmazel Ucar E, Araz O, Yilmaz N, Akgun M, Meral M, Kaynar H, Saglam L. Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic. Multidisciplinary respiratory medicine. 2014;9:1\u20135.","journal-title":"Multidisciplinary respiratory medicine"},{"issue":"3","key":"1591_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/08897077.2018.1439802","volume":"39","author":"GA Aldi","year":"2018","unstructured":"Aldi GA, Bertoli G, Ferraro F, Pezzuto A, Cosci F. Effectiveness of pharmacological or psychological interventions for smoking cessation in smokers with major depression or depressive symptoms: A systematic review of the literature. Substance abuse. 2018;39(3):289\u2013306.","journal-title":"Substance abuse"},{"issue":"11","key":"1591_CR6","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1111\/add.14721","volume":"114","author":"P Tutka","year":"2019","unstructured":"Tutka P, Vinnikov D, Courtney RJ, Benowitz NL. Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation. Addiction. 2019;114(11):1951\u201369.","journal-title":"Addiction"},{"issue":"37","key":"1591_CR7","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.2174\/1381612825666181123124733","volume":"24","author":"A Paduszy\u0144ska","year":"2018","unstructured":"Paduszy\u0144ska A, Banach M, Rysz J, D\u0105browa M, G\u0105siorek P, Bielecka-D\u0105browa A. Cytisine-from the past to the future. Curr Pharm Des. 2018;24(37):4413\u201323.","journal-title":"Curr Pharm Des"},{"key":"1591_CR8","doi-asserted-by":"crossref","unstructured":"Livingstone-Banks J, Fanshawe TR, Thomas KH, Theodoulou A, Hajizadeh A, Hartman L, Lindson N. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2023(5).","DOI":"10.1002\/14651858.CD006103.pub8"},{"key":"1591_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2023.110900","volume":"250","author":"ME Quintanilla","year":"2023","unstructured":"Quintanilla ME, Rivera-Meza M, Berr\u00edos-C\u00e1rcamo P, Cassels BK. Reduction of nicotine and ethanol intake in alcohol-preferring (UChB) female rats by the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonists 5-bromocytisine and cytisine. Drug Alcohol Depend. 2023;250: 110900.","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"1591_CR10","first-page":"777","volume":"58","author":"P Tutka","year":"2006","unstructured":"Tutka P, Zato\u00f1ski W. Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy. Pharmacol Rep. 2006;58(6):777.","journal-title":"Pharmacol Rep"},{"issue":"6","key":"1591_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/tc.2006.016097","volume":"15","author":"W Zatonski","year":"2006","unstructured":"Zatonski W, Cedzynska M, Tutka P, West R. An uncontrolled trial of cytisine (Tabex) for smoking cessation. Tob Control. 2006;15(6):481\u20134.","journal-title":"Tob Control"},{"issue":"10","key":"1591_CR12","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40263-016-0362-3","volume":"30","author":"E Beard","year":"2016","unstructured":"Beard E, Shahab L, Cummings DM, Michie S, West R. New pharmacological agents to aid smoking cessation and tobacco harm reduction: what has been investigated, and what is in the pipeline? CNS Drugs. 2016;30(10):951\u201383.","journal-title":"CNS Drugs"},{"issue":"13","key":"1591_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1056\/NEJMoa1102035","volume":"365","author":"R West","year":"2011","unstructured":"West R, Zatonski W, Cedzynska M, Lewandowska D, Pazik J, Aveyard P, Stapleton J. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med. 2011;365(13):1193\u2013200.","journal-title":"N Engl J Med"},{"issue":"25","key":"1591_CR14","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1056\/NEJMoa1407764","volume":"371","author":"N Walker","year":"2014","unstructured":"Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, et al. Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014;371(25):2353\u201362.","journal-title":"N Engl J Med"},{"key":"1591_CR15","doi-asserted-by":"publisher","first-page":"105700","DOI":"10.1016\/j.phrs.2021.105700","volume":"170","author":"C Gotti","year":"2021","unstructured":"Gotti C, Clementi F. Cytisine and cytisine derivatives. More than smoking cessation aids. Pharm Res. 2021;170:105700.","journal-title":"Pharm Res."},{"issue":"11","key":"1591_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1136\/thoraxjnl-2012-203035","volume":"68","author":"P Hajek","year":"2013","unstructured":"Hajek P, McRobbie H, Myers K. Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis. Thorax. 2013;68(11):1037\u201342.","journal-title":"Thorax"},{"issue":"1","key":"1591_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2021.7621","volume":"326","author":"RJ Courtney","year":"2021","unstructured":"Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP, et al. Effect of cytisine vs varenicline on smoking cessation: a randomized clinical trial. JAMA. 2021;326(1):56\u201364.","journal-title":"JAMA"},{"issue":"5","key":"1591_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ntr\/ntr002","volume":"13","author":"TP Thompson-Evans","year":"2011","unstructured":"Thompson-Evans TP, Glover MP, Walker N. Cytisine\u2019s potential to be used as a traditional healing method to help indigenous people stop smoking: a qualitative study with M\u0101ori. Nicotine Tob Res. 2011;13(5):353\u201360.","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"1591_CR19","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1177\/0962280215588241","volume":"25","author":"AL Whitehead","year":"2016","unstructured":"Whitehead AL, Julious SA, Cooper CL, Campbell MJ. Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable. Stat Methods Med Res. 2016;25(3):1057\u201373.","journal-title":"Stat Methods Med Res"},{"issue":"8","key":"1591_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jamapediatrics.2020.0901","volume":"174","author":"D Hammond","year":"2020","unstructured":"Hammond D, Rynard VL, Reid JL. Changes in prevalence of vaping among youths in the United States, Canada, and England from 2017 to 2019. JAMA Pediatr. 2020;174(8):797\u2013800.","journal-title":"JAMA Pediatr"},{"issue":"12","key":"1591_CR21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1080\/17425247.2020.1814736","volume":"17","author":"VV Gholap","year":"2020","unstructured":"Gholap VV, Kosmider L, Golshahi L, Halquist MS. Nicotine forms: why and how do they matter in nicotine delivery from electronic cigarettes? Expert Opin Drug Deliv. 2020;17(12):1727\u201336.","journal-title":"Expert Opin Drug Deliv"},{"issue":"11","key":"1591_CR22","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.jtho.2022.07.007","volume":"17","author":"U Pastorino","year":"2022","unstructured":"Pastorino U, Ladisa V, Trussardo S, Sabia F, Rolli L, Valsecchi C, et al. Cytisine therapy improved smoking cessation in the randomized screening and multiple intervention on lung epidemics lung cancer screening trial. J Thorac Oncol. 2022;17(11):1276\u201386.","journal-title":"J Thorac Oncol"},{"issue":"Supplement_1","key":"1591_CR23","doi-asserted-by":"publisher","first-page":"ehz748. 0077","DOI":"10.1093\/eurheartj\/ehz748.0077","volume":"40","author":"M Coja","year":"2019","unstructured":"Coja M, Mullen K, Pipe A, Reid R. 1442 Implementation and outcomes of systematic approaches to tobacco treatment: the Ottawa Model for Smoking Cessation. Eur Heart J. 2019;40(Supplement_1):ehz748. 0077.","journal-title":"Eur Heart J."},{"issue":"3","key":"1591_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2337\/dc17-1809","volume":"41","author":"RD Reid","year":"2018","unstructured":"Reid RD, Malcolm J, Wooding E, Geertsma A, Aitken D, Arbeau D, et al. Prospective, cluster-randomized trial to implement the ottawa model for smoking cessation in diabetes education programs in Ontario. Canada Diabetes Care. 2018;41(3):406\u201312.","journal-title":"Canada Diabetes Care"},{"issue":"1","key":"1591_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ntr\/ntp165","volume":"12","author":"RD Reid","year":"2010","unstructured":"Reid RD, Mullen K-A, Slovinec D\u2019Angelo ME, Aitken DA, Papadakis S, Haley PM, et al. Smoking cessation for hospitalized smokers: an evaluation of the \u201cOttawa Model.\u201d Nicotine Tob Res. 2010;12(1):11\u20138.","journal-title":"Nicotine Tob Res"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-024-01591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-024-01591-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-024-01591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T07:01:22Z","timestamp":1738047682000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-024-01591-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1591"],"URL":"https:\/\/doi.org\/10.1186\/s40814-024-01591-4","relation":{},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was granted full ethics approval by the Ottawa Health Science Network Research Ethics Board (OHSN-REB) (Reference number 20190720-01H) and it is registered to Clinicaltrials.gov (CT04286295).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable\u2014no identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent forms are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}